Mapping Interests in Event-Driven and Long-Acting Pre-exposure Prophylaxis Formulations onto the HIV Risk Environment of Street-Based Female Sex Workers: A Latent Class Analysis.
Biomedical HIV prevention
HIV pre-exposure prophylaxis
Injection drug use
Sex work
United States
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
accepted:
22
11
2021
pubmed:
2
4
2022
medline:
30
4
2022
entrez:
1
4
2022
Statut:
ppublish
Résumé
Despite growing availability, HIV pre-exposure prophylaxis (PrEP) uptake and adherence remains suboptimal among female sex workers (FSW) in the United States. Using cross-sectional data from a survey of 236 street-based cisgender FSW in Baltimore, Maryland, we examined interest in event-driven and long-acting PrEP formulations. Latent class analysis identified discrete patterns of interest in five novel PrEP agents. Multinomial latent class regression then examined factors associated with probabilistic class membership. A three-class solution emerged as the best-fit latent class model: Injectable Acceptors (~ 24% of sample), Universal Acceptors (~ 18%), and Non-Acceptors (~ 58%). Compared to Non-Acceptors, Universal Acceptors had significantly (p < 0.05) higher odds of reporting condomless vaginal sex with clients, client condom coercion, and client-perpetrated physical violence. Relative to Non-Acceptors, Injectable Acceptors were distinguished by significantly higher rates of condomless vaginal sex with clients and injection drug use. Expanding PrEP options for FSW could help overcome barriers to PrEP initiation and persistence.
Identifiants
pubmed: 35362908
doi: 10.1007/s10461-022-03613-9
pii: 10.1007/s10461-022-03613-9
pmc: PMC9050919
mid: NIHMS1795539
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1992-2002Subventions
Organisme : NIDA NIH HHS
ID : T32 DA007292
Pays : United States
Organisme : NIDA NIH HHS
ID : 5T32DA007292
Pays : United States
Organisme : Johns Hopkins Center for AIDS Research
ID : 1P30AI094189
Organisme : NIMH NIH HHS
ID : K01 MH114715
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI094189
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA038499
Pays : United States
Organisme : NIMH NIH HHS
ID : F31 MH126796
Pays : United States
Organisme : NIDA NIH HHS
ID : R01DA038499-01
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Centers for Disease Control and Prevention (CDC). HIV in the United States and dependent areas. Atlanta: CDC; 2020. https://www.cdc.gov/hiv/statistics/overview/ataglance.html . Accessed July 7, 2020.
Huang YA. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morb Mortal Wkly Rep. 2018;67. https://www.cdc.gov/mmwr/volumes/67/wr/mm6741a3.htm . Accessed July 7, 2020.
Kuteesa MO, Seeley J, Weiss HA, Cook S, Kamali A, Webb EL. Alcohol misuse and illicit drug use among occupational groups at high risk of HIV in Sub-Saharan Africa: a systematic review. AIDS Behav. 2019;23(12):3199–225.
pubmed: 30945031
doi: 10.1007/s10461-019-02483-y
Kuteesa MO, Seeley J, Cook S, Webb EL. Multi-level experiences and determinants of alcohol misuse and illicit drug use among occupational groups at high-risk of HIV in Sub-Saharan Africa: a thematic synthesis of qualitative findings. Glob Public Health. 2020;15(5):715–33.
pubmed: 31640453
doi: 10.1080/17441692.2019.1679216
Goldenberg SM, Duff P, Krusi A. Work environments and HIV prevention: a qualitative review and meta-synthesis of sex worker narratives. BMC Public Health. 2015;15:1241.
pubmed: 26672756
pmcid: 4681074
doi: 10.1186/s12889-015-2491-x
Footer KH, Silberzahn BE, Tormohlen KN, Sherman SG. Policing practices as a structural determinant for HIV among sex workers: a systematic review of empirical findings. J Int AIDS Soc. 2016;19(4 Suppl 3):20883.
pubmed: 27435716
pmcid: 4951541
doi: 10.7448/IAS.19.4.20883
Platt L, Grenfell P, Meiksin R, Elmes J, Sherman SG, Sanders T, et al. Associations between sex work laws and sex workers’ health: a systematic review and meta-analysis of quantitative and qualitative studies. PLoS Med. 2018;15(12):e1002680.
pubmed: 30532209
pmcid: 6289426
doi: 10.1371/journal.pmed.1002680
Baral S, Beyrer C, Muessig K, Poteat T, Wirtz AL, Decker MR, et al. Burden of HIV among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(7):538–49.
pubmed: 22424777
doi: 10.1016/S1473-3099(12)70066-X
Dubbink JH, Verweij SP, Struthers HE, Ouburg S, McIntyre JA, Morré SA, et al. Genital Chlamydia trachomatis and Neisseria gonorrhoeae infections among women in Sub-Saharan Africa: a structured review. Int J STD AIDS. 2018;29(8):806–24.
pubmed: 29486628
doi: 10.1177/0956462418758224
Nerlander LM, Handanagic S, Hess KL, Lutnick A, Agnew-Brune CB, Hoots BE, et al. HIV prevalence among women who exchange sex for money or drugs-4 U.S. cities. J Acquir Immune Defic Syndr 1999. 2020;84(4):345–54.
doi: 10.1097/QAI.0000000000002362
Wang Z, Lau JTF, Yang X, Cai Y, Gross DL, Ma T, et al. Acceptability of daily use of free oral pre-exposure prophylaxis (PrEP) among transgender women sex workers in Shenyang, China. AIDS Behav. 2017;21(12):3287–98.
pubmed: 28752354
doi: 10.1007/s10461-017-1869-4
Bazzi AR, Yotebieng K, Otticha S, Rota G, Agot K, Ohaga S, et al. PrEP and the syndemic of substance use, violence, and HIV among female and male sex workers: a qualitative study in Kisumu, Kenya. J Int AIDS Soc. 2019;22(4):e25266.
pubmed: 30983147
pmcid: 6462807
doi: 10.1002/jia2.25266
Glick JL, Russo R, Jivapong B, Rosman L, Pelaez D, Footer KHA, et al. The PrEP care continuum among cisgender women who sell sex and/or use drugs globally: a systematic review. AIDS Behav. 2019;24(5):1312–33.
doi: 10.1007/s10461-019-02733-z
Poteat T, Wirtz A, Malik M, Cooney E, Cannon C, Hardy WD, et al. A gap between willingness and uptake: findings from mixed methods research on HIV prevention among Black and Latina transgender women. J Acquir Immune Defic Syndr 1999. 2019;82(2):131–40.
doi: 10.1097/QAI.0000000000002112
Tomko C, Park JN, Allen ST, Glick J, Galai N, Decker MR, et al. Awareness and interest in HIV pre-exposure prophylaxis among street-based female sex workers: results from a US context. AIDS Patient Care STDs. 2019;33(2):49–57.
pubmed: 30632769
pmcid: 6386071
doi: 10.1089/apc.2018.0182
Deutsch MB, Glidden DV, Sevelius J, Keatley J, McMahan V, Guanira J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2(12):e512-519.
pubmed: 26614965
pmcid: 5111857
doi: 10.1016/S2352-3018(15)00206-4
Eakle R, Gomez GB, Naicker N, Bothma R, Mbogua J, Cabrera Escobar MA, et al. HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: results from a prospective observational demonstration project. PLoS Med. 2017;14(11):e1002444.
pubmed: 29161256
pmcid: 5697804
doi: 10.1371/journal.pmed.1002444
Kagaayi J, Batte J, Nakawooya H, Kigozi B, Nakigozi G, Strömdahl S, et al. Uptake and retention on HIV pre-exposure prophylaxis among key and priority populations in South-Central Uganda. J Int AIDS Soc. 2020;23(8):e25588.
pubmed: 32785976
pmcid: 7421540
doi: 10.1002/jia2.25588
Mutua G, Sanders E, Mugo P, Anzala O, Haberer JE, Bangsberg D, et al. Safety and adherence to intermittent pre-exposure prophylaxis (PrEP) for HIV-1 in African men who have sex with men and female sex workers. PLoS ONE. 2012;7(4):e33103.
pubmed: 22511916
pmcid: 3325227
doi: 10.1371/journal.pone.0033103
Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411–22.
pubmed: 22784040
pmcid: 3687217
doi: 10.1056/NEJMoa1202614
Choopanya K, Martin M, Suntharasamai P, Sangkum U, Mock PA, Leethochawalit M, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet Lond Engl. 2013;381(9883):2083–90.
doi: 10.1016/S0140-6736(13)61127-7
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–18.
pubmed: 25651245
pmcid: 4341965
doi: 10.1056/NEJMoa1402269
Mack N, Evens EM, Tolley EE, Brelsford K, Mackenzie C, Milford C, et al. The importance of choice in the rollout of ARV-based prevention to user groups in Kenya and South Africa: a qualitative study. J Int AIDS Soc. 2014;17(3 Suppl 2):19157.
pubmed: 25224616
pmcid: 4164014
Ye L, Wei S, Zou Y, Abdullah AS, Zhong X, Ruan Y, et al. HIV pre-exposure prophylaxis interest among female sex workers in Guangxi, China. PLoS ONE. 2014;9(1):e86200.
pubmed: 24465956
pmcid: 3899205
doi: 10.1371/journal.pone.0086200
Reza-Paul S, Lazarus L, Doshi M, Hafeez Ur Rahman S, Ramaiah M, Maiya R, et al. Prioritizing risk in preparation for a demonstration project: a mixed methods feasibility study of oral pre-exposure prophylaxis (PREP) among female sex workers in South India. PLoS ONE. 2016;11(11):e0166889.
pubmed: 27880833
pmcid: 5120793
doi: 10.1371/journal.pone.0166889
Eakle R, Bourne A, Mbogua J, Mutanha N, Rees H. Exploring acceptability of oral PrEP prior to implementation among female sex workers in South Africa. J Int AIDS Soc. 2018;21(2):e25081.
pmcid: 5817972
doi: 10.1002/jia2.25081
Footer KHA, Lim S, Rael CT, Greene GJ, Carballa-Diéguez A, Giguere R, et al. Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a U.S. city. AIDS Care. 2019;31(10):1207–13.
pubmed: 30822101
pmcid: 6663578
doi: 10.1080/09540121.2019.1587352
Emmanuel G, Folayan M, Undelikwe G, Ochonye B, Jayeoba T, Yusuf A, et al. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria. BMC Public Health. 2020;20(1):69.
pubmed: 31941469
pmcid: 6964078
doi: 10.1186/s12889-020-8195-x
Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, et al. High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya. AIDS Behav. 2013;17(6):2162–72.
pubmed: 23080358
pmcid: 3690654
doi: 10.1007/s10461-012-0317-8
Eakle R, Bothma R, Bourne A, Gumede S, Motsosi K, Rees H. “I am still negative”: female sex workers’ perspectives on uptake and use of daily pre-exposure prophylaxis for HIV prevention in South Africa. PLoS ONE. 2019;14(4):e0212271.
pubmed: 30964874
pmcid: 6456175
doi: 10.1371/journal.pone.0212271
Chakrapani V, Shunmugam M, Rawat S, Baruah D, Nelson R, Newman PA. Acceptability of HIV pre-exposure prophylaxis among transgender women in India: a qualitative investigation. AIDS Patient Care STDs. 2020;34(2):92–8.
pubmed: 31951490
doi: 10.1089/apc.2019.0237
Sherman SG, Park JN, Galai N, Allen ST, Huettner SS, Silberzahn BE, et al. Drivers of HIV infection among cisgender and transgender female sex worker populations in Baltimore City: results from the SAPPHIRE Study. J Acquir Immune Defic Syndr 1999. 2019;80(5):513–21.
doi: 10.1097/QAI.0000000000001959
Lim S, Park JN, Kerrigan DL, Sherman SG. Severe food insecurity, gender-based violence, homelessness, and HIV risk among street-based female sex workers in Baltimore, Maryland. AIDS Behav. 2019;23(11):3058–63.
pubmed: 31429031
pmcid: 6824907
doi: 10.1007/s10461-019-02643-0
Nerlander LM, Hess KL, Rose CE, Sionean C, Thorson A, Broz D, et al. Exchange sex and HIV infection among women who inject drugs-20 US cities, 2009. J Acquir Immune Defic Syndr 1999. 2017;75(Suppl 3):S333–40.
doi: 10.1097/QAI.0000000000001408
Hendrix CW. HIV antiretroviral pre-exposure prophylaxis: development challenges and pipeline promise. Clin Pharmacol Ther. 2018;104(6):1082–97.
pubmed: 30199098
doi: 10.1002/cpt.1227
Coelho LE, Torres TS, Veloso VG, Landovitz RJ, Grinsztejn B. Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipeline. Lancet HIV. 2019;6(11):e788–99.
pubmed: 31558423
doi: 10.1016/S2352-3018(19)30238-3
United States Public Health Service. Pre-exposure prophylaxis for the prevention of HIV infection in the United States—2017 update: a clinical practice guideline. Atlanta: Centers for Disease Control and Prevention (CDC); 2017. https://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2017.pdf . Accessed July 7, 2020.
HIV Prevention Trials Network. HPTN 084 study demonstrates superiority of CAB LA to oral FTC/TDF for the prevention of HIV. HPTN; 2020. https://www.hptn.org/news-and-events/press-releases/hptn-084-study-demonstrates-superiority-of-cab-la-to-oral-ftctdf-for .
Luecke EH, Cheng H, Woeber K, Nakyanzi T, Mudekunye-Mahaka IC, van der Straten A, et al. Stated product formulation preferences for HIV pre-exposure prophylaxis among women in the VOICE-D (MTN-003D) study. J Int AIDS Soc. 2016;19(20875):1–9.
Harling G, Muya A, Ortblad KF, Mashasi I, Dambach P, Ulenga N, et al. HIV risk and pre-exposure prophylaxis interest among female bar workers in Dar es Salaam: cross-sectional survey. BMJ Open. 2019;9(3):e023272.
pubmed: 30898799
pmcid: 6475445
doi: 10.1136/bmjopen-2018-023272
Hynes JS, Sales JM, Sheth AN, Lathrop E, Haddad LB. Interest in multipurpose prevention technologies to prevent HIV/STIs and unintended pregnancy among young women in the United States. Contraception. 2018;97(3):277–84.
pubmed: 29055782
doi: 10.1016/j.contraception.2017.10.006
Minnis AM, Browne EN, Boeri M, Agot K, van der Straten A, Ahmed K, et al. Young women’s stated preferences for biomedical HIV prevention: results of a discrete choice experiment in Kenya and South Africa. J Acquir Immune Defic Syndr 1999. 2019;80(4):394–403.
doi: 10.1097/QAI.0000000000001945
Shapley-Quinn MK, Manenzhe KN, Agot K, Minnis AM, van der Straten A. “We are not the same”: African women’s view of multipurpose prevention products in the TRIO clinical study. Int J Womens Health. 2019;11:97–107.
pubmed: 30799959
pmcid: 6369839
doi: 10.2147/IJWH.S185712
van den Berg JJ, Rosen RK, Bregman DE, Thompson LA, Jensen KM, Kiser PF, et al. “Set it and forget it”: women’s perceptions and opinions of long-acting topical vaginal gels. AIDS Behav. 2014;18(5):862–70.
pubmed: 24248674
pmcid: 4018755
doi: 10.1007/s10461-013-0652-4
Govender E, Abdool KQ. Understanding women and men’s acceptability of current and new HIV prevention technologies in KwaZulu-Natal, South Africa. AIDS Care. 2018;30(10):1311–4.
pubmed: 29914270
doi: 10.1080/09540121.2018.1488027
Eisingerich AB, Wheelock A, Gomez GB, Garnett G, Dybul MR, Piot PK. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. PLoS ONE. 2012;7(1):e28238.
pubmed: 22247757
pmcid: 3256136
doi: 10.1371/journal.pone.0028238
Minnis AM, Roberts ST, Agot K, Weinrib R, Ahmed K, Manenzhe K, et al. Young women’s ratings of three placebo multipurpose prevention technologies for HIV and pregnancy prevention in a randomized, cross-over study in Kenya and South Africa. AIDS Behav. 2018;22(8):2662–73.
pubmed: 29560570
pmcid: 6097726
doi: 10.1007/s10461-018-2078-5
van der Straten A, Agot K, Ahmed K, Weinrib R, Browne EN, Manenzhe K, et al. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018;21(3):e25094.
pubmed: 29600595
pmcid: 5876496
doi: 10.1002/jia2.25094
Allen ST, Footer KHA, Galai N, Park JN, Silberzahn B, Sherman SG. Implementing targeted sampling: lessons learned from recruiting female sex workers in Baltimore, MD. J Urban Health Bull N Y Acad Med. 2019;96(3):442–51.
doi: 10.1007/s11524-018-0292-0
Silberzahn BE, Morris MB, Riegger KE, White RH, Tomko CA, Park JN, et al. Barriers and facilitators to retaining a cohort of street-based cisgender female sex workers recruited in Baltimore, Maryland, USA: results from the SAPPHIRE study. BMC Public Health. 2020;20(1):585.
pubmed: 32349728
pmcid: 7191822
doi: 10.1186/s12889-020-08723-4
Rhodes T. The, “risk environment”: a framework for understanding and reducing drug-related harm. Int J Drug Policy. 2002;13(2):85–94.
doi: 10.1016/S0955-3959(02)00007-5
Footer KHA, Park JN, Allen ST, Decker MR, Silberzahn BE, Huettner S, et al. Police-related correlates of client-perpetrated violence among female sex workers in Baltimore City, Maryland. Am J Public Health. 2019;109(2):289–95.
pubmed: 30571295
pmcid: 6336048
doi: 10.2105/AJPH.2018.304809
Brantley M, Kerrigan D, German D, Lim S, Sherman S. Identifying patterns of social and economic hardship among structurally vulnerable women: a latent class analysis of HIV/STI risk. AIDS Behav. 2017;21(10):3047–56.
pubmed: 28138802
pmcid: 5592146
doi: 10.1007/s10461-017-1673-1
Footer KHA, Lim S, Brantley MR, Sherman SG. Structural risk and limits on agency among exotic dancers: HIV risk practices in the exotic dance club. Cult Health Sex. 2018;20(3):321–34.
pubmed: 28720018
doi: 10.1080/13691058.2017.1346201
Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB. The revised Conflict Tactics Scales (CTS2): development and preliminary psychometric data. J Fam Issues. 1996;17(3):283–316.
doi: 10.1177/019251396017003001
Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med. 1998;158(16):1789–95.
pubmed: 9738608
doi: 10.1001/archinte.158.16.1789
Collins LM, Lanza ST. Latent class and latent transition analysis: with applications in the social, behavioral, and health sciences. New York: Wiley; 2009.
doi: 10.1002/9780470567333
Lanza ST, Collins LM, Lemmon DR, Schafer JL. PROC LCA: a SAS procedure for latent class analysis. Struct Equ Model Multidiscip J. 2007;14(4):671–94.
doi: 10.1080/10705510701575602
Goodman LA. Exploratory latent structure analysis using both identifiable and unidentifiable models. Biometrika. 1974;61(2):215–31.
doi: 10.1093/biomet/61.2.215
Celeux G, Soromenho G. An entropy criterion for assessing the number of clusters in a mixture model. J Classif. 1996;13(2):195–212.
doi: 10.1007/BF01246098
Lo Y, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika. 2001;88(3):767–78.
doi: 10.1093/biomet/88.3.767
McCutcheon AL. Latent class analysis. Thousand Oaks: SAGE; 1987.
doi: 10.4135/9781412984713
McLachlan GJ. Mahalanobis distance. Resonance. 1999;4(6):20–6.
doi: 10.1007/BF02834632
Nagin D. Group-based modeling of development. Cambridge: Harvard University Press; 2009.
Vermunt JK. Latent class modeling with covariates: two improved three-step approaches. Polit Anal Undefined/ed. 2017;18(4):450–69.
doi: 10.1093/pan/mpq025
Rael CT, Martinez M, Giguere R, Bockting W, MacCrate C, Mellman W, et al. Transgender women’s concerns and preferences on potential future long-acting biomedical HIV prevention strategies: the case of injections and implanted medication delivery devices (IMDDs). AIDS Behav. 2019;24(5):1452–62.
doi: 10.1007/s10461-019-02703-5
Ma PHX, Chan ZCY, Loke AY. The socio-ecological model approach to understanding barriers and facilitators to the accessing of health services by sex workers: a systematic review. AIDS Behav. 2017;21(8):2412–38.
pubmed: 28631228
doi: 10.1007/s10461-017-1818-2
Croxford S, Platt L, Hope VD, Cullen KJ, Parry JV, Ncube F. Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a National Survey of Health Harms and Behaviours. Int J Drug Policy. 2015;26(4):429–33.
pubmed: 25449053
doi: 10.1016/j.drugpo.2014.09.014
Girchenko P, King EJ. Correlates of double risk of HIV acquisition and transmission among women who inject drugs in St. Petersburg, Russia. AIDS Behav. 2017;21(4):1054–8.
pubmed: 28185022
doi: 10.1007/s10461-017-1723-8
Park JN, Footer KHA, Decker MR, Tomko C, Allen ST, Galai N, et al. Interpersonal and structural factors associated with receptive syringe-sharing among a prospective cohort of female sex workers who inject drugs. Addict Abingdon Engl. 2019;114(7):1204–13.
doi: 10.1111/add.14567
Adelekan AL, Omoregie PI, Edoni ER. Sexual practices of female sex workers who inject drugs in Osogbo, Nigeria. Int Sch Res Not. 2014;2014. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897494/ (cited 1 Oct 2020).
Wirtz AL, Peryshkina A, Mogilniy V, Beyrer C, Decker MR. Current and recent drug use intensifies sexual and structural HIV risk outcomes among female sex workers in the Russian Federation. Int J Drug Policy. 2015;26(8):755–63.
pubmed: 26003930
pmcid: 4873958
doi: 10.1016/j.drugpo.2015.04.017
Biello KB, Bazzi AR, Mimiaga MJ, Biancarelli DL, Edeza A, Salhaney P, et al. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs. Harm Reduct J. 2018;15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233595/ (cited 1 Oct 2020).
Allen ST, O’Rourke A, White RH, Smith KC, Weir B, Lucas GM, et al. Barriers and facilitators to PrEP use among people who inject drugs in rural Appalachia: a qualitative study. AIDS Behav. 2020;24(6):1942–50.
pubmed: 31853771
pmcid: 7228835
doi: 10.1007/s10461-019-02767-3
Schneider KE, White RH, O’Rourke A, Kilkenny ME, Perdue M, Sherman SG, et al. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia. AIDS Care. 2020;21:1–8.
Atujuna M, Newman PA, Wallace M, Eluhu M, Rubincam C, Brown B, et al. Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: a qualitative study. PLoS ONE. 2018;13(2):e0191251.
pubmed: 29420549
pmcid: 5805172
doi: 10.1371/journal.pone.0191251
Woodsong C, Alleman P. Sexual pleasure, gender power and microbicide acceptability in Zimbabwe and Malawi. AIDS Educ Prev Off Publ Int Soc AIDS Educ. 2008;20(2):171–87.
doi: 10.1521/aeap.2008.20.2.171
Gafos M, Pool R, Mzimela MA, Ndlovu HB, McCormack S, Elford J. Communication about microbicide use between couples in KwaZulu-Natal, South Africa. AIDS Behav. 2015;19(5):832–46.
pubmed: 25488170
doi: 10.1007/s10461-014-0965-y
Robertson AM, Syvertsen JL, Martinez G, Rangel MG, Palinkas LA, Stockman JK, et al. Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico–US border cities: a mixed methods analysis. Glob Public Health. 2013;8(5):619–33.
pubmed: 23398385
pmcid: 3674154
doi: 10.1080/17441692.2012.762412
Giguere R, Frasca T, Dolezal C, Febo I, Cranston RD, Mayer K, et al. Acceptability of three novel HIV prevention methods among young male and transgender female sex workers in Puerto Rico. AIDS Behav. 2016;20(10):2192–202.
pubmed: 27048236
pmcid: 5448554
doi: 10.1007/s10461-016-1387-9